VLX600 is a novel iron-chelating inhibitor of oxidative phosphorylation, potentiated the effect of radiation in tumor spheroids in a synergistic manner. VLX600 is preferentially active against quiescent cells in colon cancer 3-D microtissues. VLX600 shows enhanced cytotoxic activity under conditions of nutrient starvation and displays tumour growth inhibition in vivo.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | VLX600 as a drug that is preferentially active against quiescent cells in colon cancer 3-D microtissues. VLX600 at 0.1 μM -10 μM inhibited the proliferation of HCT116, five additional human colon carcinoma cell lines and two mouse cell lines (T1 breast carcinoma; B16F10 melanoma) in monolayer culture over 72 h, which is associated with induction of autophagy. After exposure of monolayer cells to VLX600, the expression of COX-1, essential for mitochondrial OXPHOS decreased, which was also observed in multicellular spheroids (MCS) core regions. VLX600 induces a HIF-1α-dependent glycolytic response[1]. In vitro, imatinib plus VLX600 at doses higher than 1μM decreased GIST-T1 (Gastrointestinal stromal tumor-T1) cell viability when compared to imatinib or VLX600 alone. In vivo, VLX600 (4.5mg/kg, IV q3–4 days) treatment alone resulted in a significant decrease in GIST-T1 tumor volume compared to vehicle controls[2]. |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
3.15mL 0.63mL 0.32mL |
15.76mL 3.15mL 1.58mL |
31.51mL 6.30mL 3.15mL |
CAS号 | 327031-55-0 |
分子式 | C17H15N7 |
分子量 | 317.35 |
SMILES Code | C/C(C1=NC=CC=C1)=N\NC2=NN=C3C(NC4=C3C=CC=C4C)=N2 |
MDL No. | MFCD01305422 |
别名 | |
运输 | 蓝冰 |
InChI Key | UQOSBPRTQFFUOA-SRZZPIQSSA-N |
Pubchem ID | 6410104 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Keep in dark place, inert atmosphere, room temperature |
溶解方案 |
请根据您的动物给药指南选择适当的溶解方案。 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|